All News #Library
Biotech
Foresee Pharma Gets 4th DSMB Nod for Casppian Phase 3 in CPP
04 Feb 2026 //
PR NEWSWIRE
Foresee Pharma: Casppian Ph 3 Study Meets LH Suppression Endpoint
24 Dec 2025 //
PR NEWSWIRE
Foresee Announces Publication of Preclinical Data in the European Heart Journal
08 Nov 2023 //
PR NEWSWIRE

Market Place
Sourcing Support